Current language:
- EN English
Follow-up reply from the European Commission to the European Ombudsman's decision on how the European Commission ensures transparency in relation to experts negotiating ‘advanced purchase agreements’ with pharmaceutical companies for vaccines against COVID-19
Correspondence - Date Thursday | 19 August 2021
Case 175/2021/DL - Opened on Friday | 29 January 2021 - Decision on Monday | 22 March 2021 - Institution concerned European Commission ( No maladministration found ) - Country Belgium
Please download pdf document attached.